Treatment of Refractory Hairy Cell Leukemia with a BRAF-inhibitor: Lessons to be Learnt

Pathology and Oncology Research

Volumn 20, Issue 4, 2014, Pages 973-980

  Sári, Eszter ^a   Nagy, Zsolt György ^a   Baghy, Kornélia ^a   Rajnai, Hajnalka ^a   Bödör, Csaba ^a   Csomor, Judit ^a   Barna, Gábor ^a   Rudas, Gábor ^a   Kovalszky, Ilona ^a   Demeter, Judit ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

BRAF V600E; Hairy cell leukemia; Refractory; Vemurafenib

Indexed keywords

ALPHA INTERFERON; CD103 ANTIGEN; CD20 ANTIGEN; CLADRIBINE; GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VEMURAFENIB; ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN;

ADULT; AGED; ANEMIA; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; BRAF V600E GENE; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL FEATURE; CYTOKINE RELEASE SYNDROME; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FATIGUE; FEVER; GENE; GENE MUTATION; HAIRY CELL LEUKEMIA; HEPATOMEGALY; HEPATOSPLENOMEGALY; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LEUKOCYTE COUNT; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MALE; MARGINAL ZONE LYMPHOMA; NEUTROPHIL COUNT; PANCYTOPENIA; QUALITY OF LIFE; REMISSION; RETREATMENT; SKIN DISEASE; THROMBOCYTOPENIA; TOXICODERMA; TREATMENT DURATION; ULTRASOUND; WEAKNESS; WEIGHT REDUCTION; ANTAGONISTS AND INHIBITORS; DRUG RESISTANCE; GENETICS; LEUKEMIA, HAIRY CELL; MIDDLE AGED; MUTATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; TREATMENT OUTCOME;

EID: 84909609275     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-014-9783-9     Document Type: Article

References (24)

1. Grever MA (2010) How I Treat Hairy Cell Leukemia. Blood 115:21–28
2. Krenács L, Tóth-Lipták J, Demeter J et al (2013) Monoclonal Antibody HBME-1 Reacts with a Minor Subset of B cells with Villous Surface and can be Useful in the Diagnosis of Hairy Cell Leukemia and other Indolent Lymphoproliferations of Villous B Lymphocytes. Virchows Arch 463(6):787–794
3. Naik RR, Saven A (2012) My Treatment Approach to Hairy Cell Leukemia. Mayo Clin Proc 87(1):67–76
4. Tiacci E, Trifonov V, Schiavoni G et al (2011) BRAF Mutations in Hairy Cell Leukemia. N Engl J Med 364:2305–2315
5. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF Gene in Human Cancer. Nature 417:949–954
6. Tiacci E, Schiavoni G, Forconi F et al (2012) Simple Genetic Diagnosis of Hairy cell Leukemia by Sensitive Detection of the BRAF-V600E Mutation. Blood 119:192–195
7. Blombery PA, Wong SQ, Hewitt CA et al (2012) Detection of BRAF Mutations in Patients with Hairy Cell Leukemia and Related Lymphoproliferative Disorders. Haematologica 97:780–783
8. Boyd EM, Bench AJ, Veer MB V’t et al (2011) High Resolution Melting Analysis for Detection of BRAF exon 15 Mutations in Hairy Cell Leukaemia and Other Lymphoid Malignancies. Br J Haem 155:609–612
9. Arcaini L, Zibellini S, Boveri E et al (2012) The BRAF V600E Mutation in Hairy Cell Leukemia and other Mature B-cell Neoplasms. Blood 119:188–191
10. Lennerz JK, Klaus BM, Marienfeld RB et al (2012) Pyrosequencing of BRAF V600E in Routine Samples of Hairy Cell Leukaemia Identifies CD5+ variant Hairy Cell Leukaemia that Lacks V600E. Br J Haem 157:267–269
11. Schnittger S, Bacher U, Haferlach T et al (2012) Development and Validation of a Real-Time Quantification Assay to Detect and Monitor BRAFV600E Mutations in Hairy Cell Leukemia. Blood 119:3151–3154
12. Xi L, Arons E, Navarro W et al (2012) Both variant and IGHV4-34-Expressing Hairy Cell Leukemia Lack the BRAF V600E Mutation. Blood 119:3330–3332
13. Langabeer SE, O’Brien D, Liptrot S et al (2012) Correlation of the BRAF V600E Mutation in Hairy Cell Leukaemia with Morphology, Cytochemistry and Immunophenotype. Int J Lab Hem 34:417–421
14. Andrulis M, Penzel R, Weichert W et al (2012) Application of a BRAF V600E Mutation-Specific Antibody for the Diagnosis of Hairy Cell Leukemia. Am J SurgPathol 36(12):1796–1800
15. Laurini JA, Aoun P, Iqbaal J et al (2012) Investigation of the BRAF V600E Mutation by Pyrosequencing in Lymphoproliferative Disorders. Am J Clin Pathol 138:877–883
16. Dietrich S, Glimm H, Andrulis M et al (2012) BRAF Inhibition in Refractory Hairy-Cell Leukemia. N Engl J Med 366:2038–2040
17. Follows GA, Sims H, Bloxham DM et al (2013) Rapid Response of Biallelic BRAF V600E Mutated Hairy Cell Leukemia to Low Dose Vemurafenib. Br J Haem 161(1):150–153
18. Peyrade F, Ré D, Ginet C et al (2013) Low-Dose Vemurafenib Induces Complete Remission in a Case of Hairy-Cell Leukemia with a V600E Mutation. Haematologica 98(2):e20–e22
19. Munoz J, Schlette E, Kurzrock R (2013) Rapid Response to Vemurafenib in a Heavily Pretreated Patient with Hairy Cell Leukemia and a BRAF Mutation. J Clin Oncol 31(20):e351–e352
20. Maurer H, Haas P, Wengenmayer T et al (2013) Successful Vemurafenib Salvage Treatment in a Patient with Primary Refractory Hairy Cell Leukemia and Pulmonary Aspergillosis. Ann Hematol DOI. doi:10.1007/s.00277–013–1987–7
21. Urnova EC, Al-Radi LS, Kuzmina LA et al (2013) Successful use of Vemurafenib in a Patient with a Resistant Hairy Cell Leukemia. Ter Arkh 85(7):76–78
22. Samuel J, Macip S, Dyer MJS (2014) Efficacy of Vemurafenib in Hairy-Cell Leukemia. N Engl J Med 370:286–288
23. Dietrich S, Hüllein J, Hundemer M et al (2013) Continued Response off Treatment after BRAF Inhibition in Refractory Hairy Cell Leukemia. J Clin Oncol 31(19):e300–e303
24. Cantwell-Dorris ER, O’Leary JJ, Sheils OM (2011) BRAF V600E: Implications for Carcinogenesis and Molecular Therapy. Mol Canc Ther 3:385–394